• Ali W Bseiso MD

  • Physician - Hematology/Oncology


    • Oncology
    • 1000 North Oak Avenue 3A2 Marshfield, WI 54449
    • (715) 387-5416

Education


1996:
Fellowship, Medical Oncology, University of Texas - MD Anderson Cancer Center, Houston, TX
1994:
Fellowship, Hematology, Boston University - Boston University Medical Center (including one year of Laboratory Research at Thomas Rothstein's Lab at BU), Boston, MA
1992:
Residency, Internal Medicine, Boston University - Boston Veteran's Affairs Medical Center, Boston, MA
1990:
Internship, Transitional, Boston University - Boston Veterans Affairs Medical Center, Boston, MA
1988:
MD, Jordan University-School of Medicine, Amman, Jordan

Work Experience


2001 to Present:
Oncologist / Hematologist, Marshfield Clinic Inc. - Marshfield Center, Marshfield, WI
2001 to Present:
Attending Physician, Marshfield Clinic Inc. - Wisconsin Rapids Center, Wisconsin Rapids, WI
2001 to Present:
Attending Physician, MCHS Hospitals Inc. d/b/a Marshfield Medical Center, Marshfield, WI
1996 to 2001:
Assistant Professor of Medicine, Jordan University School of Medicine, Amman, Jordan

Board Certifications


1993 to Present:
American Board of Internal Medicine (1993), Recertified
2004 to Present:
American Board of Internal Medicine - Hematology (1994), Recertified
2007 to Present:
American Board of Internal Medicine - Medical Oncology (1997), Recertified

Professional Societies


American Society of Clinical Oncology, Member
American Society of Hematology, Member

Select Publications


  • JIANG S, KONOPLEVA M, BSEISO A, ZHAO S, ANDREEFF M. (1996). ISOTYPE CONVERSION OF CD45RA TO CD45RO AS AN EARLY EVENT IN ARA-C INDUCED APOPTOSIS OF ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) CELLS. BLOOD. 88(10):256.
  • Bseiso AW, Jiang S, Kantarjian H, Champlin R, Talpaz M, Andreeff M. (1996). Decreased expression of CD45RO on primitive hematopoietic progenitor cells (HPC) in chronic myelogenous leukemia (CML), BLOOD. 88(10):923.
  • Bseiso AW, Kantarjian H, Estey E. (1997 January). Myelodysplastic syndrome following successful therapy of acute promyelocytic leukemia. Leukemia. 11(1):168-169.
    PubMed ID: 9001434
  • Bseiso AW, Kantarjian H, Guo JQ, Cortes J, Talpaz M, Koller C,...Arlinghaus R. (1997 September). Analysis of the BCR-ABL protein in Philadelphia chromosome-positive adult acute lymphocytic leukemia. Leukemia. 11(9):1583-1587.
    PubMed ID: 9305617
  • WEBER DM, BSEISO A, WOOD A, GAVINO M, ALEXANIAN R. (1997). ALL-TRANS-RETINOIC ACID FOR MULTIPLE-MYELOMA. BLOOD. 90(10):1593.
  • Awidi A, Shannak M, Bseiso A, Kailani MA, Kailani MA, Omar N,...Sakarneh N. (1999 Apr). High prevalence of factor V Leiden in healthy Jordanian Arabs. Thromb Haemost. 81(4):582-4.
    PubMed ID: 10235443
  • Huncharek MS, Bseiso AW, Hutchins LG, Warner JJ. (2004 June). Presentation of malignant pleural mesothelioma with symptomatic brain metastasis: report of a case. Tumori. 90(4):424-427.
    PubMed ID: 15510989
  • Ali W. Bseiso, William G. Hocking, Richard J. Mercier, Bruce Krawisz, Ruemu Birhiray. (2006). CHOP-Rituximab-Interferon Therapy in Follicular Lmphoma (FL): High Remissions with Reasonable Toxicity. American Society of Hematology. 108(11):4731.
  • Bseiso AW, McLaughlin P. (2007). The indolent lymphomas. In: Pazdur R, Wagman LD, Kamphausen KA, Hoskins WJ. (Ed.), Medical Oncology: A Comprehensive Review CMP Medica.
  • Bseiso AW, Rodriguez AM. (2008). Lymphomas of the head and neck. In: Harrison, Louis B.; Sessions, Roy B.; Hong, Waun K. (Ed.), Head and Neck Cancer Lippincott Williams & Wilkins.
  • Julie E. Chang, Chong Zhang, KyungMann Kim, Rachel Kirby, Ali W. Bseiso, Lynn Volk,...Ronald S. Go. (2012). Bendamustine + Rituximab (BR) Chemoimmunotherapy and Maintenance Lenalidomide in Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL): A Wisconsin Oncology Network (WON) Study. American Society of Hematology. 120(21):3647.